Multidrug-Resistant Tuberculosis, Somalia, 2010–2011
Authors:
- Christopher FitzpatrickCFChristopher Fitzpatrick
- Dennis FalzonDFDennis Falzon
- Bashir SuleimanBSBashir Suleiman
- Peter ArubePAPeter Arube
- Ismail AdamIAIsmail Adam
- Samiha BaghdadiSBSamiha Baghdadi
- Amal BassiliABAmal Bassili
- Matteo ZignolMZMatteo Zignol
Open Access
- 1 March 2013
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 19 (3) , 478-480
Abstract
In a nationwide survey in 2011, multidrug-resistant tuberculosis (MDR TB) was found in 5.2% and 40.8% of patients with new and previously treated TB, respectively. These levels of drug resistance are among the highest ever documented in Africa and the Middle East. This finding presents a serious challenge for TB control in Somalia.Keywords
This publication has 5 references indexed in Scilit:
- A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant TuberculosisPharmacoEconomics, 2012
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateEuropean Respiratory Journal, 2011
- Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance SurveillanceThe Lancet, 2009
- GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysisEuropean Respiratory Journal, 2008
- Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South AfricaAmerican Journal of Respiratory and Critical Care Medicine, 2008